Anebulo Pharmaceuticals, Inc. (ANEB)
OTCMKTS
· Delayed Price · Currency is USD
0.455
+0.015 (3.41%)
Mar 6, 2026, 9:30 AM EST
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $18.56 million as of March 9, 2026. Its market cap has decreased by -68.08% in one year.
Market Cap
18.56M
Enterprise Value
9.52M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.46
Market Cap Chart
Since May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from 165.19M to 18.56M, a decrease of -88.77%. That is a compound annual growth rate of -36.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 18.56M | -55.28% |
| Dec 31, 2025 | 41.50M | -4.76% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -13.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oncotelic Therapeutics | 18.79M |
| Inhibitor Therapeutics | 18.24M |
| EOM Pharmaceuticals Holdings | 20.25M |
| Finch Therapeutics Group | 21.28M |
| Zeo ScientifiX | 15.76M |
| Provectus Biopharmaceuticals | 22.28M |
| HOOKIPA Pharma | 13.50M |
| NKGen Biotech | 26.12M |